1h Free Analyst Time
The systemic mastocytosis treatment market is forecasted to grow by USD 173.8 million during 2024-2029, accelerating at a CAGR of 6.5% during the forecast period. The report on the systemic mastocytosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of aging population, increasing prevalence of blood cancer, and growing healthcare expenditure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The systemic mastocytosis treatment market is segmented as below:
By Type
- AK-002
- BLU-285
- Brentuximab vedotin
- Crenolanib besylate
- Others
By Route Of Administration
- Oral
- Injectables
- Topical
By End-user
- Hospitals
- Specialty clinics
- Research and academic institutes
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the systemic mastocytosis treatment market covers the following areas:
- Systemic Mastocytosis Treatment Market sizing
- Systemic Mastocytosis Treatment Market forecast
- Systemic Mastocytosis Treatment Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Systemic Mastocytosis Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on global systemic mastocytosis treatment market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 AK-002 - Market size and forecast 2024-2029
Chart on AK-002 - Market size and forecast 2024-2029 ($ million)
Data Table on AK-002 - Market size and forecast 2024-2029 ($ million)
Chart on AK-002 - Year-over-year growth 2024-2029 (%)
Data Table on AK-002 - Year-over-year growth 2024-2029 (%)
8.4 BLU-285 - Market size and forecast 2024-2029
Chart on BLU-285 - Market size and forecast 2024-2029 ($ million)
Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million)
Chart on BLU-285 - Year-over-year growth 2024-2029 (%)
Data Table on BLU-285 - Year-over-year growth 2024-2029 (%)
8.5 Brentuximab vedotin - Market size and forecast 2024-2029
Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
8.6 Crenolanib besylate - Market size and forecast 2024-2029
Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 AK-002 - Market size and forecast 2024-2029
Chart on AK-002 - Market size and forecast 2024-2029 ($ million)
Data Table on AK-002 - Market size and forecast 2024-2029 ($ million)
Chart on AK-002 - Year-over-year growth 2024-2029 (%)
Data Table on AK-002 - Year-over-year growth 2024-2029 (%)
8.4 BLU-285 - Market size and forecast 2024-2029
Chart on BLU-285 - Market size and forecast 2024-2029 ($ million)
Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million)
Chart on BLU-285 - Year-over-year growth 2024-2029 (%)
Data Table on BLU-285 - Year-over-year growth 2024-2029 (%)
8.5 Brentuximab vedotin - Market size and forecast 2024-2029
Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
8.6 Crenolanib besylate - Market size and forecast 2024-2029
Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
9.5 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ million)
Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
9.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
9.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
9.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
9.5 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ million)
Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by End-user
10.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Specialty clinics - Market size and forecast 2024-2029
Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
10.5 Research and academic institutes - Market size and forecast 2024-2029
Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
10.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
10.4 Specialty clinics - Market size and forecast 2024-2029
Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
10.5 Research and academic institutes - Market size and forecast 2024-2029
Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
10.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AB Science SA
AB Science SA - Overview
AB Science SA - Product / Service
AB Science SA - Key offerings
SWOT
15.5 AdvaCare Pharma
AdvaCare Pharma - Overview
AdvaCare Pharma - Product / Service
AdvaCare Pharma - Key offerings
SWOT
15.6 Cogent Biosciences, Inc.
Cogent Biosciences, Inc. - Overview
Cogent Biosciences, Inc. - Product / Service
Cogent Biosciences, Inc. - Key offerings
SWOT
15.7 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.8 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
15.9 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.12 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AB Science SA
AB Science SA - Overview
AB Science SA - Product / Service
AB Science SA - Key offerings
SWOT
15.5 AdvaCare Pharma
AdvaCare Pharma - Overview
AdvaCare Pharma - Product / Service
AdvaCare Pharma - Key offerings
SWOT
15.6 Cogent Biosciences, Inc.
Cogent Biosciences, Inc. - Overview
Cogent Biosciences, Inc. - Product / Service
Cogent Biosciences, Inc. - Key offerings
SWOT
15.7 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.8 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
15.9 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.12 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Type
Exhibits 41: Data Table on Comparison by Type
Exhibits 42: Chart on AK-002 - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on AK-002 - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on AK-002 - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on AK-002 - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on BLU-285 - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on BLU-285 - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on BLU-285 - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Type ($ million)
Exhibits 63: Data Table on Market opportunity by Type ($ million)
Exhibits 64: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 65: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Route of Administration
Exhibits 67: Data Table on Comparison by Route of Administration
Exhibits 68: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 80: Market opportunity by Route of Administration ($ million)
Exhibits 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 82: Chart on End-user - Market share 2024-2029 (%)
Exhibits 83: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 84: Chart on Comparison by End-user
Exhibits 85: Data Table on Comparison by End-user
Exhibits 86: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 102: Market opportunity by End-user ($ million)
Exhibits 103: Data Table on Market opportunity by End-user ($ million)
Exhibits 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 107: Chart on Geographic comparison
Exhibits 108: Data Table on Geographic comparison
Exhibits 109: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 165: Market opportunity By Geographical Landscape ($ million)
Exhibits 166: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 167: Impact of drivers and challenges in 2024 and 2029
Exhibits 168: Overview on criticality of inputs and factors of differentiation
Exhibits 169: Overview on factors of disruption
Exhibits 170: Impact of key risks on business
Exhibits 171: Companies covered
Exhibits 172: Company ranking index
Exhibits 173: Matrix on companies position and classification
Exhibits 174: AB Science SA - Overview
Exhibits 175: AB Science SA - Product / Service
Exhibits 176: AB Science SA - Key offerings
Exhibits 177: SWOT
Exhibits 178: AdvaCare Pharma - Overview
Exhibits 179: AdvaCare Pharma - Product / Service
Exhibits 180: AdvaCare Pharma - Key offerings
Exhibits 181: SWOT
Exhibits 182: Cogent Biosciences, Inc. - Overview
Exhibits 183: Cogent Biosciences, Inc. - Product / Service
Exhibits 184: Cogent Biosciences, Inc. - Key offerings
Exhibits 185: SWOT
Exhibits 186: Dr Reddys Laboratories Ltd. - Overview
Exhibits 187: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 188: Dr Reddys Laboratories Ltd. - Key news
Exhibits 189: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 190: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 191: SWOT
Exhibits 192: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 193: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 194: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 195: SWOT
Exhibits 196: Lupin Ltd. - Overview
Exhibits 197: Lupin Ltd. - Business segments
Exhibits 198: Lupin Ltd. - Key news
Exhibits 199: Lupin Ltd. - Key offerings
Exhibits 200: Lupin Ltd. - Segment focus
Exhibits 201: SWOT
Exhibits 202: Novartis AG - Overview
Exhibits 203: Novartis AG - Business segments
Exhibits 204: Novartis AG - Key news
Exhibits 205: Novartis AG - Key offerings
Exhibits 206: Novartis AG - Segment focus
Exhibits 207: SWOT
Exhibits 208: Pfizer Inc. - Overview
Exhibits 209: Pfizer Inc. - Product / Service
Exhibits 210: Pfizer Inc. - Key news
Exhibits 211: Pfizer Inc. - Key offerings
Exhibits 212: SWOT
Exhibits 213: Sanofi SA - Overview
Exhibits 214: Sanofi SA - Business segments
Exhibits 215: Sanofi SA - Key news
Exhibits 216: Sanofi SA - Key offerings
Exhibits 217: Sanofi SA - Segment focus
Exhibits 218: SWOT
Exhibits 219: Inclusions checklist
Exhibits 220: Exclusions checklist
Exhibits 221: Currency conversion rates for US$
Exhibits 222: Research methodology
Exhibits 223: Information sources
Exhibits 224: Data validation
Exhibits 225: Validation techniques employed for market sizing
Exhibits 226: Data synthesis
Exhibits 227: 360 degree market analysis
Exhibits 228: List of abbreviations
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Type
Exhibits 41: Data Table on Comparison by Type
Exhibits 42: Chart on AK-002 - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on AK-002 - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on AK-002 - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on AK-002 - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on BLU-285 - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on BLU-285 - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on BLU-285 - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on BLU-285 - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Brentuximab vedotin - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Brentuximab vedotin - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Crenolanib besylate - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Crenolanib besylate - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by Type ($ million)
Exhibits 63: Data Table on Market opportunity by Type ($ million)
Exhibits 64: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 65: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 66: Chart on Comparison by Route of Administration
Exhibits 67: Data Table on Comparison by Route of Administration
Exhibits 68: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 80: Market opportunity by Route of Administration ($ million)
Exhibits 81: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 82: Chart on End-user - Market share 2024-2029 (%)
Exhibits 83: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 84: Chart on Comparison by End-user
Exhibits 85: Data Table on Comparison by End-user
Exhibits 86: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 102: Market opportunity by End-user ($ million)
Exhibits 103: Data Table on Market opportunity by End-user ($ million)
Exhibits 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 107: Chart on Geographic comparison
Exhibits 108: Data Table on Geographic comparison
Exhibits 109: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 165: Market opportunity By Geographical Landscape ($ million)
Exhibits 166: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 167: Impact of drivers and challenges in 2024 and 2029
Exhibits 168: Overview on criticality of inputs and factors of differentiation
Exhibits 169: Overview on factors of disruption
Exhibits 170: Impact of key risks on business
Exhibits 171: Companies covered
Exhibits 172: Company ranking index
Exhibits 173: Matrix on companies position and classification
Exhibits 174: AB Science SA - Overview
Exhibits 175: AB Science SA - Product / Service
Exhibits 176: AB Science SA - Key offerings
Exhibits 177: SWOT
Exhibits 178: AdvaCare Pharma - Overview
Exhibits 179: AdvaCare Pharma - Product / Service
Exhibits 180: AdvaCare Pharma - Key offerings
Exhibits 181: SWOT
Exhibits 182: Cogent Biosciences, Inc. - Overview
Exhibits 183: Cogent Biosciences, Inc. - Product / Service
Exhibits 184: Cogent Biosciences, Inc. - Key offerings
Exhibits 185: SWOT
Exhibits 186: Dr Reddys Laboratories Ltd. - Overview
Exhibits 187: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 188: Dr Reddys Laboratories Ltd. - Key news
Exhibits 189: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 190: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 191: SWOT
Exhibits 192: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 193: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 194: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 195: SWOT
Exhibits 196: Lupin Ltd. - Overview
Exhibits 197: Lupin Ltd. - Business segments
Exhibits 198: Lupin Ltd. - Key news
Exhibits 199: Lupin Ltd. - Key offerings
Exhibits 200: Lupin Ltd. - Segment focus
Exhibits 201: SWOT
Exhibits 202: Novartis AG - Overview
Exhibits 203: Novartis AG - Business segments
Exhibits 204: Novartis AG - Key news
Exhibits 205: Novartis AG - Key offerings
Exhibits 206: Novartis AG - Segment focus
Exhibits 207: SWOT
Exhibits 208: Pfizer Inc. - Overview
Exhibits 209: Pfizer Inc. - Product / Service
Exhibits 210: Pfizer Inc. - Key news
Exhibits 211: Pfizer Inc. - Key offerings
Exhibits 212: SWOT
Exhibits 213: Sanofi SA - Overview
Exhibits 214: Sanofi SA - Business segments
Exhibits 215: Sanofi SA - Key news
Exhibits 216: Sanofi SA - Key offerings
Exhibits 217: Sanofi SA - Segment focus
Exhibits 218: SWOT
Exhibits 219: Inclusions checklist
Exhibits 220: Exclusions checklist
Exhibits 221: Currency conversion rates for US$
Exhibits 222: Research methodology
Exhibits 223: Information sources
Exhibits 224: Data validation
Exhibits 225: Validation techniques employed for market sizing
Exhibits 226: Data synthesis
Exhibits 227: 360 degree market analysis
Exhibits 228: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global systemic mastocytosis treatment market: AB Science SA, AdvaCare Pharma, Cogent Biosciences, Inc., Dr Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Sanofi SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in diagnostic technologies for systemic mastocytosis management."
According to the report, one of the major drivers for this market is the growth of aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Science SA
- AdvaCare Pharma
- Cogent Biosciences Inc.
- Dr Reddys Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
